Search

IQVIA will likely use the Medera partnership to deepen its advanced-R&D pitch, while investors watch whether guidance gains convert into earnings.

This is a useful signal on where large clinical-services players are trying to grow: AI, real-world evidence and next-generation therapies. Investors will watch whether the narrative translates into margin expansion.